Skip to content

Substance Use Disorders Assessment and Treatment

Spend $50 to get a free DVD!

ISBN-10: 0122191609

ISBN-13: 9780122191602

Edition: 2000

Authors: Charles E. Dodgen, W. Michael Shea

List price: $86.95
Shipping box This item qualifies for FREE shipping.
Blue ribbon 30 day, 100% satisfaction guarantee!
Rent eBooks
Buy eBooks
what's this?
Rush Rewards U
Members Receive:
Carrot Coin icon
XP icon
You have reached 400 XP and carrot coins. That is the daily max!


Substance Use Disorders: Assessment and Treatment is a summary of everything a therapist should know about substance abuse in one easy-to-read comprehensive book. The book begins with a discussion of the pharmacology of specific drug classes (opioids, hallucinogens, etc.) and the epidemiology of abuse. It then presents psychological theories of substance abuse, the initiation and progression of substance abuse disorders, issues of prevention and early intervention, and screening and assessment for substance abuse (including specific tests for assessment) and discusses in detail the various treatment methodologies available. Two final chapters explore issues relevant to special populations and legal and ethical considerations, regarding issues such as confidentiality and coerced treatment. Key Features * A synthesis of the current research and clinical literature * Includes strengths and weaknesses of commonly used psychometric assessment measures * Presentation and review of a complete Psychosocial/Substance Use Assessment form * Discussion of treatment settings and criteria for placement decisions * Discussion of treatment alternatives and effectiveness of major pharmacological and psychotherapeutic approaches * Discussion of factors leading to Relapse, and components of Relapse Prevention programs
Customers also bought

Book details

List price: $86.95
Copyright year: 2000
Publisher: Elsevier Science & Technology Books
Publication date: 5/3/2000
Binding: Hardcover
Pages: 173
Size: 6.25" wide x 9.50" long x 0.75" tall
Weight: 0.946

Clinical Pharmacology and Clinical Epidemiology of Psychoactive Substances
Definitions and General Concepts of Pharmacology
Pharmacology of Individual Drugs
Central Nervous System Stimulants
Central Nervous System Depressants
Psilocybin and Psilocin
Solvent and Aerosol Inhalants
Clinical Epidemiology of Psychoactive Substances
General Trends
Trends of Specific Substance Use
Other CNS Depressants
CNS Stimulants
Etiology of Psychoactive Substance Use Disorders
Theories of Etiology
Genetic Research
Psychological Theories
Psychodynamic Theories
Behavioral/Cognitive-Behavioral Theories
Family Models
Initiation, Progression, and Maintenance of Psychoactive Substance Use Disorders
Stage Models of Adolescent Substance Use
Risk Factors
Risk Factors for Use versus Abuse
Adult Model of Substance Use
Course/Natural History of Psychoactive Substance Use Disorders
The Disease Model
Classic Model of Progression of Alcoholism
Longitudinal Study of Alcohol Abuse
Models of Progression of Substance Use
Stage Model of Progression
Spontaneous Remission of Substance Abuse
Stages of Change Model
Prevention, Early Intervention, and Harm Reduction
General Perspective
Types of Prevention
Targets of Prevention Efforts
Types of Interventions
Supply Reduction/Legal Interventions
Risk and Protective Factors
Risk Factors
Broad Social and Cultural Factors Associated with Elevated Risk of Substance Abuse
Individual and Interpersonal Environmental Factors Associated with Elevated Risk of Substance Abuse
Protective Factors Mitigating Risk of Substance Abuse
Skills Training
Community-Based Prevention
School-Based Programs
Parenting/Family Interventions
Related Risks/Harm Reduction
HIV and Substance Abuse
Pregnant Adolescents/Adolescent Mothers
Reducing Alcohol Consumption
Screening and Assessment of Psychoactive Substance Use
Overview of the Assessment Process
Stage Models of Assessment
Illustrative Stage Models of Assessment of Psychoactive Substance Use Disorders
Validity of Self-Report Data
Factors Associated with Accurate Self-Report of Psychoactive Substance Use
Psychometric Properties of Assessment Instruments
Alcohol Screening Instruments
Michigan Alcohol Screening Test (MAST)
CAGE Questionnaire
Alcohol Use Disorders Identification Test (AUDIT)
MacAndrew Alcoholism Scale (MAC)
Adolescent-Specific Scales
Adolescent Alcohol Involvement Scale (AAIS)
MacAndrew Alcoholism Scale for Adolescents (MAC-A)
Rutgers Alcohol Problem Index (RAPI)
Drug Screening Instruments
Drug Abuse Screening Test (DAST)
Drug Use Screening Inventory (DUSI)
Biological Screening Measures
Alcohol-Specific Biological Screening Measures
Measurement of Recent Use
Measurement of Long-Term Alcohol Abuse
Laboratory Assessment of Drugs Other Than Alcohol
Methods of Measurement of Recent Use
Assessment of Chronic Drug Abuse
Diagnostic Instruments
The Alcohol Use Disorders and Associated Disabilities Interview Schedule (AUDADIS)
Composite International Diagnostic Interview: Authorized Core Version 1.0 (CIDI-Core)
Structured Clinical Interview for DSM III-R (SCID)
Addiction Severity Index (ASI)
Fagerstrom Tolerance Questionnaire (FTQ)
Clinical Institute Withdrawal Assessment-Revised (CIWA-AR)
Knowledge of Symptoms of Withdrawal and Intoxication
Measures of Consumption of Alcohol and Other Substances
Lifetime Drinking History (LDH)
Quantity-Frequency Methods (QF)
Timeline Follow Back (TLFB)
Knowledge of High-Risk Groups
Knowledge of Diagnostic Criteria
Areas to Assess for Treatment Planning Purposes
Neuropsychological Screening
Expectancy Measures
Assessment of Motivation for Change
Assessment of High-Risk Situations
Assessment of Family Functioning
Awareness of Common Family Dynamics
Illustrative Example and Discussion of a Complete Psychosocial/Substance Use Assessment Form
Presentation of the Assessment Form
Examples of Specific Questions to Ask and Rationales for Inclusion of Items on the Assessment Form
Diagnosis and Comorbidity
Definition and Prevalence
Percentage of Alcohol Abusers Presenting with Comorbid Psychiatric Disorders
Percentage of Drug Abusers Presenting with Comorbid Psychiatric Disorders
Percentage of Psychiatric Cases Presenting with Substance Abuse or Dependence
Diagnostic Issues of the Dually Impaired
Complicating Factors
Improvement of Diagnostic Validity
Illustrative Clinical Cases
Treatment of the Dually Diagnosed
Traditional Approaches
Parallel Treatment Systems
Integrated Treatment Systems
Treatment I: Models and Approaches
Treatment Settings and Services
Placement Criteria
Major Theoretical Treatment Approaches
Current Psychoanalytic/Psychodynamic Approaches
Neurotic Conflict
Ego- and Self-Deficits
Deficits in Affective Functioning and Object Relations
Psychosomatic Disorders
Elements Common to Psychoanalytic Theories of Substance Abuse
Strengths and Weaknesses of Psychoanalytic Theories of Substance Abuse
Family Therapies
Family Disease Model
Behavioral Model
Family Systems Model
Strengths and Weaknesses of Family Theories of Substance Abuse
Behavioral/Cognitive Behavioral Approaches
Classical Conditioning
Operant Conditioning
Social Learning Theory
Strengths and Weaknesses of Behavioral Approaches to the Treatment of Substance Abuse
Client-Centered/Motivational Interviewing
Biopsychosocial Model
12-Step Programs
Therapeutic Community
Additional Psychological Therapies
Social Skills Training
Contingency Management
Aversion Therapies
Community Reinforcement Approach (CRA)
Relapse Prevention
Common Elements of Relapse Prevention Programs
Cue Exposure
Behavioral Self-Control
Stress Management
Network Therapy
Role of Pharmacotherapy
Treatment Effectiveness/Outcome Studies
Therapist Factors
Patient Factors
Program Services
Duration of Treatment
Theoretical Orientation
Alternative Treatments
Transcendental Meditation (TM)
Concluding Remarks on Acupuncture and TM
Treatment II: Planning, Implementing, and Managing Treatment and the Course of Recovery
Phases of Recovery
Relapse Parameters
Treatment Goals
Traditional Abstinence Goals
Controlled Use of Alcohol
Engagement of Patients in Treatment
Client-Treatment Matching
Project Match
Treatment of Family Members of Substance Abusers
Linkage of Services
Treatment of Criminal Offenders
Driving-Related Offenders
Treatment of the Incarcerated
Self-Help Groups
Alcoholics Anonymous (AA) and Narcotics Anonymous (NA)
Women for Sobriety
Rational Recovery
Issues in Specific Populations
Impaired Physicians
Definition and Risk Factors
Treatment of Physicians
Ethnic Minorities
Prevalence and Etiological Factors
Cultural Influences on Substance Abuse
Treatment of Ethnic Minorities
Barriers to Treatment for Ethnic Minorities
Prevalence of Substance Abuse
Barriers to Treatment for Women
Treatment Needs of Women
Prevention with Adolescents
Barriers to Treatment for Adolescents
Barriers to Treatment and Treatment Needs of Those with HIV/AIDS
The Elderly Population
Diagnostic Issues
Treatment of the Elderly Population
The Homeless Population
Prevalence of Substance Abuse
Underutilization of Services
Legal and Ethical Issues
Rationale for Confidentiality
Federal Guidelines for Valid Consent to Disclose Information
Disclosure without Patient Consent
Confidentiality and HIV Status
Confidentiality and Illegal Behavior
Confidentiality and Minors
Responsibility to Diagnose and Treat Substance Use Disorders
Coerced Treatment
Driving While Intoxicated (DWI) Programs
Referral for Treatment by Social Service Agencies
Treatment of Pregnant Mothers
Americans with Disabilities Act (ADA)
Description of the ADA
Application of the ADA to Substance Abusers